Watch for Adbry, Cibinqo, and Rinvoq for Eczema

March 2022

More meds for moderate to severe atopic dermatitis will try to squeeze into the market...Adbry, Cibinqo, and Rinvoq.

Save these specialty meds for when topicals (steroids, etc) aren’t enough. Include these in the EHR, even if you’re not prescribing them.

Adbry (tralokinumab) is similar to Dupixent (dupilumab). Both are injectable monoclonal antibodies that reduce inflammation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote